Laryngeal Diseases D007818

Diseases [C] » Respiratory Tract Diseases [C08] » Laryngeal Diseases

Diseases [C] » Otorhinolaryngologic Diseases [C09] » Laryngeal Diseases

Description

Pathological processes involving any part of the LARYNX which coordinates many functions such as voice production, breathing, swallowing, and coughing.   MeSH

Subtype Terms (14)

Granuloma, Laryngeal
2 approved drugs

Laryngeal Edema
2 approved drugs

Laryngeal Neoplasms
41 drugs (28 approved, 13 experimental)

Laryngeal Nerve Injuries
 

Laryngitis
4 drugs (3 approved, 1 experimental)

Laryngocele
 

Laryngomalacia
3 approved drugs

Laryngopharyngeal Reflux
11 drugs (8 approved, 3 experimental)

Laryngostenosis
3 drugs (2 approved, 1 experimental)

Supraglottitis
 

Tuberculosis, Laryngeal
 

Vocal Cord Dysfunction
16 drugs (11 approved, 5 experimental)

Vocal Cord Paralysis
4 drugs (1 approved, 3 experimental)

Voice Disorders
7 drugs (5 approved, 2 experimental)


Phase 4 Indicated Drugs (1)

Phase 2 Indicated Drugs (1)


Organization Involved with Phase 4 Indications (1)

Organization Involved with Other Experimental Indications (3)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.